Literature DB >> 12604699

Molecular determinants of melanocortin 4 receptor ligand binding and MC4/MC3 receptor selectivity.

Sarah A Nickolls1, Mary I Cismowski, Xiaochuan Wang, Meira Wolff, Paul J Conlon, Richard A Maki.   

Abstract

The molecular basis of ligand recognition by the melanocortin 4 receptor (MC4R) has not been fully defined. In this study, we investigated the molecular determinants of MC4R ligand binding, employing a large array of ligands, using three approaches. First, molecular modeling of the receptor was used to identify Phe284, in transmembrane (TM) 7, as a potential site of ligand interaction. Mutation of Phe284 to alanine reduced binding affinity and potency of peptides containing L-Phe by up to 71-fold but did not appreciably affect binding of linear peptides containing D-Phe, consistent with a hydrophobic interaction between the Phe7 of alpha-melanocyte-stimulating hormone and Phe284. Second, we examined the effect of a naturally occurring mutation in TM3 (I137T) that is linked to obesity. This mutation decreased affinity and potency of cyclic, rigid peptides but not more flexible peptides, consistent with an indirect effect of the mutation on the tertiary structure of the receptor. Third, we examined the residues that support ligand selectivity for the MC4R over the MC3R. Mutation of Ile125 (TM3) of the MC4R to the equivalent residue of the MC3R (phenylalanine) selectively decreased affinity and potency of MC4R-selective ligands. This effect was mirrored by the reciprocal MC3R mutation F157I. The magnitude of this effect indicates that this locus is not of major importance. However, it is considered that an isoleucine/phenylalanine mutation may affect the orientation of Asp122, which has been identified as a major determinant of ligand binding affinity. Thus, this study provides further characterization of the MC4R binding pocket.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12604699     DOI: 10.1124/jpet.102.044974

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  17 in total

1.  Interactions of human melanocortin 4 receptor with nonpeptide and peptide agonists.

Authors:  Irina D Pogozheva; Biao-Xin Chai; Andrei L Lomize; Tung M Fong; David H Weinberg; Ravi P Nargund; Michael W Mulholland; Ira Gantz; Henry I Mosberg
Journal:  Biochemistry       Date:  2005-08-30       Impact factor: 3.162

2.  Melanocortin tetrapeptide Ac-His-DPhe-Arg-Trp-NH2 modified at the para position of the benzyl side chain (DPhe): importance for mouse melanocortin-3 receptor agonist versus antagonist activity.

Authors:  Bettina Proneth; Irina D Pogozheva; Federico P Portillo; Henry I Mosberg; Carrie Haskell-Luevano
Journal:  J Med Chem       Date:  2008-09-25       Impact factor: 7.446

3.  The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

Review 4.  Structure, function and regulation of the melanocortin receptors.

Authors:  Yingkui Yang
Journal:  Eur J Pharmacol       Date:  2011-01-03       Impact factor: 4.432

5.  The melanocortin-4 receptor: physiology, pharmacology, and pathophysiology.

Authors:  Ya-Xiong Tao
Journal:  Endocr Rev       Date:  2010-02-26       Impact factor: 19.871

6.  Molecular basis for the selectivity of the mammalian bombesin peptide, neuromedin B, for its receptor.

Authors:  Nieves González; Tomoo Nakagawa; Samuel A Mantey; Veronica Sancho; Hirotsugu Uehara; Tatsuro Katsuno; Robert T Jensen
Journal:  J Pharmacol Exp Ther       Date:  2009-07-23       Impact factor: 4.030

7.  Semi-rigid tripeptide agonists of melanocortin receptors.

Authors:  Andrew R Ruwe; Leonid Koikov; Zalfa Abdel-Malek; Carrie Haskell-Luevano; Marvin L Dirain; Federico Portillo; Zhimin Xiang; Matt Wortman; James J Knittel
Journal:  Bioorg Med Chem Lett       Date:  2009-07-09       Impact factor: 2.823

8.  Functions of acidic transmembrane residues in human melanocortin-3 receptor binding and activation.

Authors:  Shu-Xiu Wang; Zhen-Chuan Fan; Ya-Xiong Tao
Journal:  Biochem Pharmacol       Date:  2008-07-09       Impact factor: 5.858

9.  In silico mutagenesis: a case study of the melanocortin 4 receptor.

Authors:  Yana Bromberg; John Overton; Christian Vaisse; Rudolph L Leibel; Burkhard Rost
Journal:  FASEB J       Date:  2009-05-05       Impact factor: 5.191

10.  Chemogenomic analysis of G-protein coupled receptors and their ligands deciphers locks and keys governing diverse aspects of signalling.

Authors:  Jörg D Wichard; Antonius Ter Laak; Gerd Krause; Nikolaus Heinrich; Ronald Kühne; Gunnar Kleinau
Journal:  PLoS One       Date:  2011-02-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.